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University of Southern Denmark 
Evaporative Crystallization of Carbamazepine 
From Different Organic Solvents 
INTRODUCTION RESULTS 
Crystallization is the most widely used technique for the final 
purification of active pharmaceutical ingredients as it allows to 
engineer the desired final product qualities such as particle size, 
shape and the polymorphic form. Selection of an appropriate 
polymorph during formulation of pharmaceuticals is very crucial as 
the important properties such as bioavailability of drug varies with 
different polymorphs. The polymorphic form crystallized during 
manufacturing process depends upon number of parameters such 
as type of crystallization process used, operating temperature, 
solvents, fluid dynamics inside the crystallizer etc. A slight variation 
in one of the parameter can give rise to a new polymorph, which 
may have totally different properties than the desired one. Anti-viral 
drug ritonavir is well known example of pharmaceutical which was 
subsequently withdrawn from market due to appearance of new 
polymorph during storage having different solubility. Therefore, it is 
necessary to study in detail the polymorphic behavior of active 
pharmaceutical ingredient at different possible operating conditions 
so that the most stable polymorph is chosen for formulation process. 
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OBJECTIVE OF THE STUDY 
In the present work, evaporative crystallization of anticonvulsant 
drug carbamazepine (CBZ) which is known to form four different 
polymorphs is performed from different organic solvents at two 
different temperatures. Aim of this study was to evaluate the effect of 
following parameters on polymorphic behavior of carbamazepine: 
 
 type of supersaturation employed during crystallization 
 different organic solvents 
 different operating temperature 
Solvent CBZ polymorph from evaporative crystallization 
Solubility 
parameter 
(MPa0.5) 
Methanol Form III 28.94 
Ethanol Mixture of Form I and III 25.92 
Acetonitrile Form III 23.86 
2-propanol Form II (major) and I 23.00 
Dichloromethane* Form II (major) and I 19.76 
Acetone Form III 19.49 
2-butanone Form II (major) and I 18.60 
Ethyl acetate Form II (major) and I 17.74 
EXPERIMENTAL 
EXPERIMENTAL SETUP 
Fig. 2: XRPD patterns of CBZ crystals obtained during evaporative 
crystallization experiments at 298.15 K along with calculated XRPD 
patterns of CBZ polymorphs I, II and III. 
* Evaporative crystallization for dichloromethane was performed at 298.15 K and 323.15 
K due to its lower boiling point (308.15 K). 
Tab. 1: Summary of the results obtained from XRPD measurements.  
CONCLUSIONS  
  In general, solvents with higher solubility parameter favor the 
crystallization of form III while the solvents with lower solubility 
parameter favor the crystallization of form II.  
 Temperature didn’t show any significant effects on the 
crystallization of the polymorphs 
Fig 3: Total solubility parameters of the solvents and CBZ plotted 
against their partial solubility parameters; a) dispersion, b) polarity, 
and c) hydrogen bonding solubility parameter. 
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Fig 1: Photograph of experimental set up. A) Combined orbital 
shaking water bath for solubility measurement; B) Rotor vacuum 
evaporator 
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